Breast cancer screening: “reassuring” the worried well?

Scandinavian Journal of Public Health

Volumn 39, Issue 3, 2011, Pages 326-332

  Brodersen, John ^a   Siersma, Volkert ^a   Ryle, Mette ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Adverse effects; breast cancer; mass screening

Indexed keywords

AGED; ARTICLE; BREAST TUMOR; COMPARATIVE STUDY; FEMALE; HUMAN; MAMMOGRAPHY; MASS SCREENING; MIDDLE AGED; PSYCHOLOGICAL ASPECT; QUESTIONNAIRE;

AGED; BREAST NEOPLASMS; FEMALE; HUMANS; MAMMOGRAPHY; MASS SCREENING; MIDDLE AGED; QUESTIONNAIRES;

EID: 79955158736     PISSN: 14034948     EISSN: None     Source Type: Journal    
DOI: 10.1177/1403494810396558     Document Type: Article

References (29)

1. Holland W.W., Stewart S. Screening in Disease Prevention. What works? Oxford: Radcliffe Publishing; 2005.
2. Lightfoot N., Steggles S., Wilkinson D., Bissett R., Bakker D., Darlington G., et al. The short-term psychological impact of organised breast cancer screening. Current Oncology 1994;1:206-11.
3. Brett J., Bankhead C., Henderson B., Watson E., Austoker J. The psychological impact of mammographic screening: a systematic review. Psychooncology 2005;14:917-38.
4. Weller A., Hener T. Invasiveness of medical procedures and state anxiety in women. Behav Med 1993;19:60-65.
5. Lerman C., Rimer B., Trock B., Balshem A., Engstrom P.F. Factors associated with repeat adherence to breast cancer screening. Prevent Med 1990;19:279-90.
6. Brodersen J., Thorsen H. Consequences of Screening in Breast Cancer (COS-BC): development of a questionnaire. Scand J Prim Health Care 2008;26:251-6.
7. Brodersen J., Thorsen H., Kreiner S. Validation of a condition-specific measure for women having an abnormal screening mammography. Value Health 2007;10:294-304.
8. Brodersen J. Measuring psychosocial consequences of false-positive screening results - breast cancer as an example. Copenhagen: Department of General Practice, Institute of Public Health, Faculty of Health Sciences, University of Copenhagen: Månedsskrift for Praktisk Lægegerning; 2006. ISBN 87-88638-36-7.
9. Kendrick D., Fielding K., Bentley E., Kerslake R., Miller P., Pringle M. Radiography of the lumbar spine in primary care patients with low back pain: randomised controlled trial. BMJ 2001;322:400-5.
10. Idestrom M., Milsom I., Andersson-Ellstrom A., Athlin E. Cervical cancer screening - “For better or worse. ”: women’s experience of screening. Cancer Nurs 2006;29:453-460.
11. Domenighetti G., D’Avanzo B., Egger M., Berrino F., Perneger T., Mosconi P., et al. Women’s perception of the benefits of mammography screening: population-based survey in four countries. Int J Epidemiol 2003;32:816-21.
12. Gotzsche P.C., Nielsen M. Screening for breast cancer with mammography. Cochrane Database Syst Rev 2009;4:CD001877.
13. Webster P., Austoker J. Women’s knowledge about breast cancer risk and their views of the purpose and implications of breast screening - a questionnaire survey. J Public Health (Oxf) 2006;28:197-202.
14. Welch H.G., Black W.C. Overdiagnosis in cancer. J Natl Cancer Inst 2010;102:605-13.
15. Njor S.H., Olsen A.H., Schwartz W., Vejborg I., Lynge E. Predicting the risk of a false-positive test for women following a mammography screening programme. J Med Screen 2007;14:94-97.
16. Elmore J.G., Barton M.B., Moceri V.M., Polk S., Arena P.J., Fletcher S.W. Ten-year risk of false positive screening mammograms and clinical breast examinations. N Eng J Med 1998;338:1089-96.
17. Hofvind S., Thoresen S., Tretli S. The cumulative risk of a false-positive recall in the Norwegian Breast Cancer Screening Program. Cancer 2004;101:1501-7.
18. Anderssen J. No går det på helsa laus. Helse, sykdom og risiko for sykdom i to nord-norske kystsamfunn [“Now it has become a health treat”. Health, disease and risk for disease in two coastal communities in nothern Norway] Tromsø: Institutt for sosiologi og Institutt for samfunnsmedisin, University of Tromsø; 1998.
19. Netterstrom B., Kristensen T.S., Sjol A. Psychological job demands increase the risk of ischaemic heart disease: a 14-year cohort study of employed Danish men. Eur J Cardiovasc Prev Rehabil 2006;13:414-20.
20. Jorgensen K.J., Gotzsche P.C. Content of invitations for publicly funded screening mammography. BMJ 2006;332:538-41.
21. Jorgensen K., Klahn A., Gotzsche P. Are benefits and harms in mammography screening given equal attention in scientific articles? A cross-sectional study. BMC Med 2007;5:12.
22. Gummersbach E., Piccoliori G., Zerbe C.O., Altiner A., Othman C., Rose C., et al. Are women getting relevant information about mammography screening for an informed consent: a critical appraisal of information brochures used for screening invitation in Germany, Italy, Spain and France. Eur J Public Health 2010 ;20(4):409-14.
23. Kvernrød A-B and Holten I. Mammografi. Undersøgelse for brystkræft. ISBN: 87-90212-77-0. 2001. Copenhagen: The Danish Cancer Society. http://www.cancer.dk/NR/rdonlyres/C58CE0B6-7DC9-4AE9-BCDE-6218C2FA320C/0/Pjeceommammografiscreening.pdf ( 2001, consulted October 2010).
24. Brodersen J., Hovelius B., Hvas L. (red). Skapar vården ohälsa? Allmänmedicinska reflektioner [Does the Health Care System Induce Harm? - Reflections from the Perspective of General Practice]. Lund: Studentlitteratur AB; 2009. ISBN 978-91-44-05255-7.
25. Rai T., Clements A., Bukach C., Shine B., Austoker J., Watson E. What influences men’s decision to have a prostate-specific antigen test? A qualitative study. Fam Pract 2007;24:365-71.
26. Thornton H., Edwards A., Baum M. Women need better information about routine mammography. BMJ 2003;327:101-3.
27. Gotzsche P.C., Hartling O.J., Nielsen M., Brodersen J., Jorgensen K.J. Breast screening: the facts - or maybe not. BMJ 2009;338:446-8.
28. Barry M.J., Mulley AJ Jr. Why are a high overdiagnosis probability and a long lead time for prostate cancer screening so important? J Natl Cancer Inst 2009;101:362-3.
29. Hvas L., Reventlow S., Jensen H.L., Malterud K. Awareness of risk of osteoporosis may cause uncertainty and worry in menopausal women. Scand J Public Health 2005;33:203-7.